| 【公司研究】伟能集团 (1608 HK) – 上半年盈利胜预期；下半年持续高增长 |
| 【Company Research】New China Life - H (1336 HK) – Disappointing NBV growth, but EV beat |
| 【Company Research】Shimao (813 HK) – Giant aircraft takes off |
| 【Company Research】Anta Sports (2020 HK) – Solid profitability and promising guidance |
| 【Company Research】Yongda (3669 HK) – Optimizing asset structure for a better future |
| 【Company Research】FinVolution (FINV US) – Soft new loans but asset quality a bright spot |
| 【Company Research】CSC Financial (6066 HK) – Prop-trading gains excelled |
| 【Company Research】China Taiping (966 HK) – Suffering 1H20, in hope for 2H20 |
| 【Company Research】Poly Property Services (6049 HK) – Visible momentum in community VAS |
| 【Company Research】I-Mab BioPharma (IMAB US) – Innovation for biologics |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
